SCHEMBL2718802

SCHEMBL2718802

CN=C=Nc1ccc(I)cc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15581836 0.79 MEN1 (0.33)
SCHEMBL2719850 0.78 IDO1 (0.33)
SCHEMBL2719590 0.78 KDM1A (0.36)
SCHEMBL28232289 0.77
SCHEMBL624867 0.77 CYP3A4 (0.38)
SCHEMBL990169 0.77 ABCB11 (0.33)
SCHEMBL2720648 0.75 MAP2K2 (0.31)
SCHEMBL4701911 0.71 ABCB11 (0.30)
SCHEMBL10145983 0.70 MAP2K2 (0.33)
SCHEMBL11882705 0.69 SLC22A2 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109320513-B Method for synthesizing trametinib 安庆奇创药业有限公司 2021-03-16 CN claimed
CN-109320513-B Method for synthesizing trametinib 安庆奇创药业有限公司 2021-03-16 CN disclosed
US-9617261-B2 Substituted pyridinone compounds as MEK inhibitors CMG PHARMACEUTICAL CO., LTD. (KR) 2017-04-11 US disclosed
US-9617261-B2 Substituted pyridinone compounds as MEK inhibitors CMG PHARMACEUTICAL CO., LTD. (KR) 2017-04-11 US disclosed
US-9617261-B2 Substituted pyridinone compounds as MEK inhibitors CMG PHARMACEUTICAL CO., LTD. (KR) 2017-04-11 US disclosed
EP-2635587-B1 6-ARYLAMINO PYRIDONE CARBOXAMIDE AS MEK INHIBITORS CENTAURUS BIOPHARMA CO LTD (CN) 2017-02-15 EP disclosed
EP-2635587-B1 6-ARYLAMINO PYRIDONE CARBOXAMIDE AS MEK INHIBITORS CENTAURUS BIOPHARMA CO LTD (CN) 2017-02-15 EP disclosed
US-9540396-B2 6-arylamino pyridone carboxamide as MEK inhibitors CENTAURUS BIOPHARMA CO., LTD. (CN) 2017-01-10 US disclosed
US-9540396-B2 6-arylamino pyridone carboxamide as MEK inhibitors CENTAURUS BIOPHARMA CO., LTD. (CN) 2017-01-10 US disclosed
US-9540396-B2 6-arylamino pyridone carboxamide as MEK inhibitors CENTAURUS BIOPHARMA CO., LTD. (CN) 2017-01-10 US disclosed
US-20140080804-A1 NOVEL 6-ARYLAMINO PYRIDONE CARBOXAMIDE AS MEK INHIBITORS CENTAURUS BIOPHARMA CO., LTD. (CN) 2014-03-20 US disclosed
US-20140080804-A1 NOVEL 6-ARYLAMINO PYRIDONE CARBOXAMIDE AS MEK INHIBITORS CENTAURUS BIOPHARMA CO., LTD. (CN) 2014-03-20 US disclosed
US-20140080804-A1 NOVEL 6-ARYLAMINO PYRIDONE CARBOXAMIDE AS MEK INHIBITORS CENTAURUS BIOPHARMA CO., LTD. (CN) 2014-03-20 US disclosed
EP-2635587-A1 NOVEL 6-ARYLAMINO PYRIDONE CARBOXAMIDE AS MEK INHIBITORS Centaurus Biopharma Co., Ltd. (CN) 2013-09-11 EP disclosed
US-20120238599-A1 HETEROCYCLIC COMPOUNDS AS MEK INHIBITORS CHEMIZON, A DIVISION OF OPTOMAGIC CO., LTD. (KR) 2012-09-20 US disclosed
US-20120238599-A1 HETEROCYCLIC COMPOUNDS AS MEK INHIBITORS CHEMIZON, A DIVISION OF OPTOMAGIC CO., LTD. (KR) 2012-09-20 US disclosed
US-20120238599-A1 HETEROCYCLIC COMPOUNDS AS MEK INHIBITORS CHEMIZON, A DIVISION OF OPTOMAGIC CO., LTD. (KR) 2012-09-20 US disclosed
WO-2012059041-A1 NOVEL 6-ARYLAMINO PYRIDONE CARBOXAMIDE AS MEK INHIBITORS CENTAURUS BIOPHARMA CO., LTD. (CN) 2012-05-10 WO disclosed
WO-2012059041-A1 NOVEL 6-ARYLAMINO PYRIDONE CARBOXAMIDE AS MEK INHIBITORS CENTAURUS BIOPHARMA CO., LTD. (CN) 2012-05-10 WO disclosed
WO-2010145197-A1 NOVEL 6-ARYLAMINO PYRIDONE SULFONAMIDES AND 6-ARYLAMINO PYRAZINONE SULFONAMDIES AS MEK INHIBITORS CHEMIZON (BEIJING), LTD. (CN) 2010-12-23 WO disclosed